Related Products
ENZANAMO 40MG
ENZANAMO 40 MG is a high-quality allopathic oncology formulation offered by Sigma Nexus, a leading pharmaceutical exporter and supplier based in Jaipur, India. With over 10 years of industry expertise, Sigma Nexus is dedicated to providing safe, effective, and globally compliant medicines to international and domestic markets. Manufactured in WHO-GMP and ISO-certified facilities, ENZANAMO 40 MG meets stringent international quality standards, ensuring reliability, safety, and consistent therapeutic performance.
ENZANAMO 40 MG is primarily used in the treatment of hormone-sensitive cancers, especially advanced prostate cancer. It belongs to a class of medications known as androgen receptor inhibitors. The medicine works by blocking the effects of male hormones (androgens) that promote the growth of cancer cells. By inhibiting these signals, ENZANAMO 40 MG helps slow down or stop the progression of cancer, making it an essential component in modern targeted cancer therapy.
Formulated using high-purity active pharmaceutical ingredients (APIs), ENZANAMO 40 MG ensures optimal absorption and effective action within the body. Sigma Nexus follows strict quality control and assurance processes at every stage—from sourcing raw materials to final product packaging—ensuring that each batch meets international pharmaceutical benchmarks. This commitment to quality makes the product suitable for hospitals, oncology clinics, distributors, and global pharmaceutical importers.
Sigma Nexus has built a strong presence in global markets including the USA, UK, UAE, Africa, and Southeast Asia. The company’s efficient logistics and supply chain network ensures timely delivery and uninterrupted supply of critical oncology medicines like ENZANAMO 40 MG. Each product is securely packaged to maintain stability, potency, and shelf life during transportation and storage under varying environmental conditions.
In addition to supplying finished formulations, Sigma Nexus offers value-added services such as third-party manufacturing and private labeling for ENZANAMO 40 MG. These services allow international clients to customize branding, packaging, and product specifications according to their local market requirements. The company also provides comprehensive product registration support, assisting clients in meeting regulatory requirements across different countries.
ENZANAMO 40 MG should be used strictly under the supervision of a qualified healthcare professional. The dosage and treatment duration depend on the patient’s medical condition, stage of cancer, and response to therapy. Its targeted mechanism of action and proven clinical effectiveness make it a vital medicine in advanced oncology care.
With a strong focus on quality, compliance, and customer satisfaction, Sigma Nexus continues to expand its global footprint as a reliable pharmaceutical exporter from India. By offering advanced oncology solutions like ENZANAMO 40 MG, the company plays a key role in improving access to life-saving treatments worldwide, contributing to better healthcare outcomes and enhanced patient well-being.